Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Lu AG09222 for the Prevention of Migraine in Patients With Unsuccessful Prior Preventive Treatments

NCT05133323 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT05133323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05133323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Lu AG09222 for the Prevention of Migraine in Patients With Unsuccessful Prior Preventive Treatments
Lead sponsor
H. Lundbeck A/S
Phase
Phase 2
Overall status
Completed
Start date
November 11, 2021
Completion date
March 16, 2023
Enrollment
237 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

migraine